Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Yamazaki

Showing results (101-110 of 252) with videos related to

Pageof 26
Sort By:
Investigational New Drugs|March 15, 2012
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumoursYasuhito Fujisaka, Yusuke Onozawa, Takayasu Kurata, et al.
Journal of Cosmetic Dermatology|July 12, 2024
Neuromuscular electrical stimulation for facial wrinkles and sagging: The 8-week prospective, split-face, controlled trial in AsiansJun Omatsu, Takashi Yamashita, Toko Mori, et al.
BMC Cancer|August 5, 2023
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)Naoki Takahashi, Hiroki Hara, Kengo Nagashima, et al.
Cancers|July 2, 2020
Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510GHiroya Taniguchi, Takeharu Yamanaka, Daisuke Sakai, et al.
Japanese Journal of Clinical Oncology|February 29, 2012
Safety, efficacy and pharmacokinetics of neratinib (HKI-272) in Japanese patients with advanced solid tumors: a Phase 1 dose-escalation studyYoshinori Ito, Mitsukuni Suenaga, Kiyohiko Hatake, et al.
Japanese Journal of Clinical Oncology|October 17, 2012
Clinical outcome of Japanese metastatic colorectal cancer patients harbouring the KRAS p.G13D mutation treated with cetuximab + irinotecanHideaki Bando, Takayuki Yoshino, Satoshi Yuki, et al.
BMC Cancer|September 7, 2013
Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kitHideaki Bando, Takayuki Yoshino, Eiji Shinozaki, et al.
BMC Palliative Care|August 24, 2024
Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexiaAri Nishimura, Satoshi Hamauchi, Akifumi Notsu, et al.
Japanese Journal of Clinical Oncology|July 25, 2014
Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosaTaro Funakoshi, Hirofumi Yasui, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|June 5, 2026
Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancerYusuke Miyajima, Takeshi Kawakami, Akifumi Notsu, et al.
Pageof 26

Showing results (101-110 of 252) with videos related to

Sort By:
Pageof 26
Investigational New Drugs|March 15, 2012
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumoursYasuhito Fujisaka, Yusuke Onozawa, Takayasu Kurata, et al.
Journal of Cosmetic Dermatology|July 12, 2024
Neuromuscular electrical stimulation for facial wrinkles and sagging: The 8-week prospective, split-face, controlled trial in AsiansJun Omatsu, Takashi Yamashita, Toko Mori, et al.
BMC Cancer|August 5, 2023
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)Naoki Takahashi, Hiroki Hara, Kengo Nagashima, et al.
Cancers|July 2, 2020
Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510GHiroya Taniguchi, Takeharu Yamanaka, Daisuke Sakai, et al.
Japanese Journal of Clinical Oncology|February 29, 2012
Safety, efficacy and pharmacokinetics of neratinib (HKI-272) in Japanese patients with advanced solid tumors: a Phase 1 dose-escalation studyYoshinori Ito, Mitsukuni Suenaga, Kiyohiko Hatake, et al.
Japanese Journal of Clinical Oncology|October 17, 2012
Clinical outcome of Japanese metastatic colorectal cancer patients harbouring the KRAS p.G13D mutation treated with cetuximab + irinotecanHideaki Bando, Takayuki Yoshino, Satoshi Yuki, et al.
BMC Cancer|September 7, 2013
Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kitHideaki Bando, Takayuki Yoshino, Eiji Shinozaki, et al.
BMC Palliative Care|August 24, 2024
Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexiaAri Nishimura, Satoshi Hamauchi, Akifumi Notsu, et al.
Japanese Journal of Clinical Oncology|July 25, 2014
Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosaTaro Funakoshi, Hirofumi Yasui, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|June 5, 2026
Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancerYusuke Miyajima, Takeshi Kawakami, Akifumi Notsu, et al.
Pageof 26